These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 37288306)

  • 1. Stimuli-responsive polymeric nanomaterials for rheumatoid arthritis therapy.
    Xie Y; Tuguntaev RG; Mao C; Chen H; Tao Y; Wang S; Yang B; Guo W
    Biophys Rep; 2020 Oct; 6(5):193-210. PubMed ID: 37288306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimuli-responsive Drug Delivery Systems as an Emerging Platform for Treatment of Rheumatoid Arthritis.
    Xu XL; Lu KJ; Yao XQ; Ying XY; Du YZ
    Curr Pharm Des; 2019; 25(2):155-165. PubMed ID: 30907308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising role of polymeric nanoparticles in the treatment of rheumatoid arthritis.
    Siddique R; Mehmood MH; Haris M; Saleem A; Chaudhry Z
    Inflammopharmacology; 2022 Aug; 30(4):1207-1218. PubMed ID: 35524837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment.
    Zhang M; Hu W; Cai C; Wu Y; Li J; Dong S
    Mater Today Bio; 2022 Mar; 14():100223. PubMed ID: 35243298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric nanocarriers as stimuli-responsive systems for targeted tumor (cancer) therapy: Recent advances in drug delivery.
    Alsehli M
    Saudi Pharm J; 2020 Mar; 28(3):255-265. PubMed ID: 32194326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid-loaded pH/ROS dual-responsive nanoparticles alleviate joint destruction by downregulating the NF-κB signaling pathway.
    Lu Y; Zhou J; Wang Q; Cai J; Yu B; Dai Q; Bao Y; Chen R; Zhang Z; Zhang D; Hou T
    Acta Biomater; 2023 Jul; 164():458-473. PubMed ID: 37072065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer nanotherapeutics: A versatile platform for effective rheumatoid arthritis therapy.
    Nooreen R; Nene S; Jain H; Prasannanjaneyulu V; Chitlangya P; Otavi S; Khatri DK; Raghuvanshi RS; Singh SB; Srivastava S
    J Control Release; 2022 Aug; 348():397-419. PubMed ID: 35660632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Move to Nano-Arthrology: Targeted Stimuli-Responsive Nanomedicines Combat Adaptive Treatment Tolerance (ATT) of Rheumatoid Arthritis.
    Liu L; Guo W; Liang XJ
    Biotechnol J; 2019 Jan; 14(1):e1800024. PubMed ID: 30221835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery.
    Cheng R; Meng F; Deng C; Klok HA; Zhong Z
    Biomaterials; 2013 May; 34(14):3647-57. PubMed ID: 23415642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
    Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimuli-responsive Polymeric Nanosystems for Therapeutic Applications.
    Handa M; Singh A; Flora SJS; Shukla R
    Curr Pharm Des; 2022; 28(11):910-921. PubMed ID: 34879797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomaterials Manipulate Macrophages for Rheumatoid Arthritis Treatment.
    Li S; Su J; Cai W; Liu JX
    Front Pharmacol; 2021; 12():699245. PubMed ID: 34335264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in intelligent-responsive nanocarriers for cancer therapy.
    Tian M; Xin X; Wu R; Guan W; Zhou W
    Pharmacol Res; 2022 Apr; 178():106184. PubMed ID: 35301111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems.
    Sethuraman V; Janakiraman K; Krishnaswami V; Kandasamy R
    Curr Drug Targets; 2021; 22(8):947-966. PubMed ID: 33511953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox Nano-Architectures: Perspectives and Implications in Diagnosis and Treatment of Human Diseases.
    Sufi SA; Pajaniradje S; Mukherjee V; Rajagopalan R
    Antioxid Redox Signal; 2019 Feb; 30(5):762-785. PubMed ID: 29334759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical review on the dissemination of PH and stimuli-responsive polymeric nanoparticular systems to improve drug delivery in cancer therapy.
    Bhattacharya S; Prajapati BG; Singh S
    Crit Rev Oncol Hematol; 2023 May; 185():103961. PubMed ID: 36921781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Potential of Nanocarriers in the Management of Rheumatoid Arthritis.
    Mittal V; Sharma A; Sharma D
    Curr Rheumatol Rev; 2024 Jul; ():. PubMed ID: 39082179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of stimuli-responsive nanocarriers for drug and gene delivery.
    Ganta S; Devalapally H; Shahiwala A; Amiji M
    J Control Release; 2008 Mar; 126(3):187-204. PubMed ID: 18261822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy.
    Saravanakumar K; Hu X; Ali DM; Wang MH
    Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction-responsive polymers for drug delivery in cancer therapy-Is there anything new to discover?
    Monteiro PF; Travanut A; Conte C; Alexander C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1678. PubMed ID: 33155421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.